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Abstract Plectin is a large, 500-kDa, intermediate fila-
ment (IF)-associated protein. It acts as a cytoskeletal
crosslinker and signaling scaffold, affecting mechanical as
well as dynamic properties of the cytoskeleton. As a
member of the plakin family of cytolinker proteins, plectin
has a multidomain structure that is responsible for its vast
binding portfolio. It not only binds to all types of IFs, actin
filaments and microtubules, but also to transmembrane
receptors, proteins of the subplasma membrane protein
skeleton, components of the nuclear envelope, and several
kinases with known roles in migration, proliferation, and
energy metabolism of cells. Due to alternative splicing,
plectin is expressed as various isoforms with differing
N-terminal heads that dictate their differential subcellular
targeting. Through specific interactions with other proteins
at their target sites and their ability to bind to all types of
IFs, plectin molecules provide strategically located IF
anchorage sites within the cytoplasm of cells. In this
review, we will present an overview of the structural
features and functional properties of plectin and discuss
recent progress in defining the role of its isoforms in stress-
prone tissues and the implicated diseases, with focus on
skin, skeletal muscle, and Schwann cells of peripheral
nerve.
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Introduction
The cytolinker protein plectin, although able to interact
with actin filaments and microtubules, is primarily an
intermediate filament (IF)-binding protein. In this capacity,
it anchors IFs to strategic cellular sites such as focal
adhesions, desmosomes and hemidesmosomes (HDs),
Z-disks and costameres, intercalated disks, as well as the
nuclear, mitochondrial, and subplasma membrane skeleton,
conferring mechanical stability to the IF network and
thereby to the cell. Structurally, plectin bears no similarity
to IF proteins except for possessing a central, in this case
unusually long, a-helical coiled coil rod domain that
mediates dimerization and higher oligomer formation and
is instrumental for networking and bridging different cel-
lular structures. As plectin is expressed in practically all
cell types, plectin mutations result in a pleiotropic pheno-
type affecting simultaneously several tissues primarily
skin, muscle, and nerve.
Plectin, an IF-associated protein
Plectin was originally isolated from IF-enriched prepara-
tions of rat glioma C6 cells (Pytela and Wiche 1980). A
few years later, a protein then named 300 K intermediate
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filament-associated protein (IFAP-300 K) was isolated
from baby hamster kidney (BHK-21) cells based on its
ability to codistribute with vimentin IFs (Lieska et al.
1985). In 1992, a protein referred to as HD-1 was identified
as a major component of HDs isolated from bovine corneal
epithelial cells (Hieda et al. 1992). With the advent of
molecular cloning and sequencing, it was possible to show
that the three proteins were identical (Clubb et al. 2000;
Okumura et al. 1999; Wiche et al. 1991). In addition to its
copurification and colocalization with IFs, plectin has been
shown to directly bind to several IF subunit proteins
including vimentin, glial fibrillary acid protein, neurofila-
ments (Foisner et al. 1988), desmin (Reipert et al. 1999),
type I and II keratins (Geerts et al. 1999; Steinbo¨ck et al.
2000), and lamin B (Foisner et al. 1991). There is evidence
that plectin-IF interactions are modulated by phosphory-
lation (Herrmann and Wiche 1983, 1987). For example,
plectin dissociates from vimentin upon phosphorylation by
protein kinase C (PKC), whereas binding to vimentin is
enhanced by cAMP-dependent protein kinase (PKA)
phosphorylation (Foisner et al. 1991). Likewise, plectin’s
association with lamin B is significantly decreased upon
PKA- and PKC-phosphorylation of either binding partner
(Foisner et al. 1991). During mitosis, plectin is phosphor-
ylated by the cyclin-dependent kinase CDK1, triggering its
dissociation from vimentin (Foisner et al. 1996). As the
various plectin isoforms allocate IF-docking sites to dif-
ferent subcellular locations, plectin molecules exert a sig-
nificant influence over the spatial and temporal distribution
of IF networks (Wiche and Winter 2011; and see below).
Plectin: more than a crosslinker of the cytoskeleton
Besides its association with IFs, plectin has been shown to
interact with the other two major cytoskeletal filament
systems, actin-based microfilaments, and microtubules
(MTs). Plectin interaction with the microfilament system
was demonstrated by ultrastructural studies using immu-
nogold-labeled antibodies to plectin. When whole mount
electron microscopy was applied to glioma C6 cells,
plectin was detected as thin (3-nm) filamentous structures
that linked IFs (vimentin) to each other and also to actin
filaments (Foisner et al. 1995). This association is consis-
tent with plectin’s occurrence at microfilament–plasma
membrane junctions in all types of muscle (Wiche et al.
1983), its buildup at focal adhesions, and its colocalization
with actin stress fibers (Andra¨ et al. 1998). Furthermore,
plectin has a functional actin-binding domain (ABD; Andra¨
et al. 1998) that is structurally similar to those of the
spectrin/dystrophin superfamily of actin-binding proteins
(Fontao et al. 2001, Garcı´a-Alvarez et al. 2003, Sevcı´k
et al. 2004). The binding affinity of plectin for actin is
comparable to that of other actin-binding proteins (Andra¨
et al. 1998) such as dystonin (Yang et al. 1996), tensin (Lo
et al. 1994), and dystrophin (Jarrett and Foster 1995). The
involvement and impact of plectin linking IFs to focal
adhesions has recently been established (Bhattacharya et al.
2009; Burgstaller et al. 2010).
Plectin has been shown to bind to microtubule-associ-
ated proteins (MAPs; Herrmann and Wiche 1987), to
copurify with MTs through repeated cycles of in vitro
assembly/disassembly (Koszka et al. 1985), to form cross-
bridges between IFs and MTs in fibroblasts depleted of the
actin cytoskeleton (Svitkina et al. 1996), and to be part of
the MT interactome during cell division (Gache et al. 2010;
Mack and Compton 2001; Sauer et al. 2005). In a very
recent report, it was shown that plectin binds to MAP2 via
its SH3 domain. By seizing MAP2, plectin antagonizes
MAP-mediated MT stabilization, and thus, destabilizes
MTs (Valencia et al. 2013).
As plectin deficiency favors stress fiber formation and
reduces MT dynamics, the binding of plectin to microfil-
aments and MTs cannot merely be seen as providing a
structural scaffold but rather as contributing to their
dynamic regulation.
Gene structure: alternative splicing as a source
of functional diversity
Plectin has been cloned from a rat glioma C6 cell cDNA
library (Wiche et al. 1991), a human placenta cDNA library
(Liu et al. 1996), and a mouse skeletal muscle cDNA
library (Fuchs et al. 1999). Likewise, plectin’s gene locus
has been analyzed in human (Liu et al. 1996; McLean et al.
1996), rat (Elliott et al. 1997), and mouse (Fuchs et al.
1999) genomes. The human plectin gene was mapped to
8q24 at the end of the long arm of chromosome 8 (Liu et al.
1996; McLean et al. 1996), and the mouse gene to a syn-
tenic region on chromosome 15 (Fuchs et al. 1999); the rat
gene is located on chromosome 7 (RefGene, GeneID:
64204). The gene spans over 62 kb and is split into 41
exons. The most striking feature is that multiple variable
first exons are spliced into a common exon 2 (Fig. 1a, b).
Nine of these exons (1-1g, 1k) are first coding exons (Fuchs
et al. 1999; McInroy and Ma¨a¨tta¨ 2011), while the coding
regions of three others (1h-1j) start in exon 6, generating
variants lacking most of plectin’s (exons 2–8 encoded)
ABD (Rezniczek et al. 2003). Downstream of exon 2 there
are 31 mostly constant exons, with exons 2–8, encoding the
ABD (Liu et al. 1996; Sevcik et al. 2004). Two additional
small exons, 2a and 3a, within the ABD-encoding genomic
region are optionally spliced within exons 2 and 4. The
following 22 exons, exons 9–30, encode the plakin domain
(see below) of plectin, whereas single large exons (31 and
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32) encode the central and C-terminal domains, respec-
tively. Low level expression of a variant-lacking rod-
encoding exon 31 has also been reported (Elliott et al.
1997; Fuchs et al. 2005).
The particular structure of the plectin gene has unveiled
the mechanism for the generation of transcript variants
differing only in their first coding exon, as each of the 12
variable exons is separately spliced into a common set of
Fig. 1 Schematic representation of the plectin gene and the encoded
protein. a Genomic organization of the plectin gene. Variable first
coding exons are represented by colored boxes, constant exons by
black boxes, introns by lines, and splicing by diagonal lines with the
color code as for the exons; arrows indicate direction of transcription.
b Transcripts generated by alternative splicing of the 50 end of the
gene. Exons are indicated by boxes, orange areas within the boxes
denote noncoding regions, black areas, coding regions. Brown boxes
indicate coding sequences if preceded by one of the first coding exons
(1-1g, 1k), or noncoding sequences if preceded by one of the
noncoding exons (1h-1j). The black area within exon 6 denotes the
first coding region of transcripts starting with exons 1h, 1i, and 1j.
Two optionally spliced exons inserted between exons 2 and 4 are
shown in red. c Accession numbers of plectin transcript variants and
isoforms. d Schematic representation of the protein. The N-terminal
domain contains an actin-binding domain (ABD) consisting of two
calponin homology domains (dark and light red), and a plakin domain
comprising nine spectrin repeats (green) and one SH3 domain
(yellow). The central rod domain is a 200-nm-long coiled coil. The
C-terminal domain contains six plectin repeat domains, each consist-
ing of a conserved region, referred to as module (blue), and a linker
region, one of which harbors the IF-binding domain (IFBD, light
blue). The different N termini of the isoforms are indicated by a star.
Positions of the mapped binding regions to various proteins are
indicated below the scheme
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downstream exons. A similar gene structure has been found
only in a few other genes (Zhang et al. 2004). Thus, most
plectin isoforms differ just in their short N-terminal
sequences (Fig. 1b). These short sequences are of crucial
importance, however, as they determine the cellular
localization of the isoforms and confer their tissue-specific
expression (Rezniczek et al. 2003). Plectin isoform 1 (P1),
for example, is targeted to the nucleus/ER membrane
(Rezniczek et al. 2003), plectin 1a (P1a) to HDs (Andra¨
et al. 2003), P1b to mitochondria (Winter et al. 2008), P1c
to MTs (Valencia et al. 2013), P1d to Z-disks (Konieczny
et al. 2008), and P1f to focal adhesions and costameres
(Burgstaller et al. 2010, Konieczny et al. 2008).
Expression and cellular localization
Plectin is expressed in a wide variety of tissues and cell
types, and it is particularly abundant in tissues subjected to
great mechanical stress, such as stratified and simple epi-
thelia, skeletal and heart muscle, and blood vessels (Wiche
et al. 1983, 1984). At the cellular level, plectin is found at
plasma membrane attachment sites of IFs and microfila-
ments, for instance, Z-disks in stratified muscle, dense
plaques in smooth muscle, intercalated disks in cardiac
muscle, HDs in the basal cell layer of stratified epithelia,
desmosomes, and focal adhesions. Furthermore, plectin
accumulates in cells forming tissue layers at the interface
between tissues and fluid-filled cavities such as kidney
glomeruli, liver bile canaliculi, bladder urothelium, gut
villi, ependymal cell layers lining the cavities of brain and
spinal cord, gial-endothelial interfaces, and endothelial
cells of blood vessels (Errante et al. 1994; Lie et al. 1998;
Wiche et al. 1983; Yaoita et al. 1996). Plectin is also a
major component of trabecular meshwork cells of the eye
which control intraocular pressure (Inoue et al. 2010).
Protein structure and binding partners
Full-length plectin is expressed as a 499–533-kDa protein
depending on the particular plectin isoform. Using rotary
shadowing electron microscopy, plectin has been visual-
ized as a dumbbell-like structure comprising a central
200-nm-long rod domain flanked by two large globular
domains (Foisner and Wiche 1987). This structure has been
confirmed by secondary structure predictions based on
plectin’s amino acid sequence (Wiche et al. 1991). Func-
tionally, plectin is a multidomain protein with similarities
to other cytoskeletal proteins of the plakin family (Son-
nenberg and Liem 2007). The amino-terminal domain
harbors a conventional ABD preceding the plakin domain
(Fig. 1d). The ABD is composed of two calponin homol-
ogy domains closely resembling the ABD of fimbrin
(Sevcı´k et al. 2004), whereas the plakin domain comprises
nine spectrin repeats with one Src-homology 3 (SH3)
domain inserted in repeat 5 (Sonnenberg et al. 2007). The
central rod domain contains an almost continuous 1127
residue long, mainly a-helical coiled coil showing long
stretches of heptads repeats with a staggered charge peri-
odicity of 10.4 for both acidic and basic residues (Wiche
et al. 1991). The C-terminal domain contains six plectin
repeat domains (PRDs) and a short terminal tail. Each PRD
is built up of a conserved core region and short linker
sequences connecting the cores (Janda et al. 2001, Wiche
et al. 1991). The PRDs are most likely tightly packed
through interlinkage by hydrogen bonds and disulfide
bridges (Spurny et al. 2007), forming a compact C-terminal
globular domain. The C-terminal tail represents a 70 resi-
dues long serine-rich region.
As a protein composed of multiple functional domains,
plectin is able to interact with a vast array of different
proteins via one or more of those domains (Figs. 1d, 2).
Thereby it can act as a mechanical reinforcement or a
scaffold for signaling molecules, or both. Plectin binds to
vimentin (Nikolic et al. 1996), desmin (Favre et al. 2011;
Reipert et al. 1999), glial fibrillary acidic protein (Foisner
et al. 1988), lamin B (Foisner et al. 1991), and cytokeratins
(Steinbo¨ck et al. 2000) via an IF-binding site located in the
linker region between PRDs 5 and 6. The IF-binding site
has been further narrowed down to a stretch of *50 amino
acids containing a basic residue cluster typically found in
nuclear localization signals (Nikolic et al. 1996). The ABD
of plectin turned out to be multifunctional, binding not only
to actin (Fuchs et al. 1999) but also to integrin b4 via the
first pair of fibronectin type III repeats (Geerts et al. 1999;
Rezniczek et al. 1998), vimentin (Sevcik et al. 2004), ne-
sprin 3 (Wilhelmsen et al. 2005), the EF-ZZ domain of
dystrophin and utrophin (Rezniczek et al. 2007), and cal-
modulin (Kostan et al. 2009). Binding of F-actin and
integrin b4 to the ABD of plectin has been shown to be
mutually exclusive (Geerts et al. 1999; Litjens et al. 2003).
Additional binding sites for integrin b4 and b-dystroglycan
have been mapped to the plakin and C-terminal repeat
domains of plectin (Koster et al. 2004; Rezniczek et al.
1998, 2007). The plakin domain also serves as a binding
site for the hemidesmosomal transmembrane protein, bul-
lous pemphigoid antigen 180 (BPAG2; Koster et al. 2003),
and the nonreceptor tyrosine kinase Fer (Lunter and Wiche
2002). Furthermore, the SH3 domain embedded in the
plakin domain serves as a docking site for MAP2 (Valencia
et al. 2013). Regarding the rod domain, there is evidence
that it mediates plectin self-association via coiled coil
interactions (Foisner and Wiche 1987; Walko et al. 2011).
It also recruits caspase 8 that cleaves plectin toward the end
of the rod (Asp 2395) in the early stages of apoptosis
(Stegh et al. 2000). Plectin is rich in cysteine residues (34
in humans) half of which are spread over its C-terminal
36 Histochem Cell Biol (2013) 140:33–53
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globular domain. One of these, a highly reactive cysteine
present in PRD5, has been shown to serve as a target for
nitrosylation in vitro and presumably is also the one
responsible for plectin’s nitrosylation observed in vivo
(Spurny et al. 2007). The phosphorylation site for mitotic
CDK1 has been mapped to threonine 4542 (Swiss-Prot:
P30427) at the end of PRD 6 (Malecz et al. 1996), and a
high-affinity binding site for the ubiquitin ligase Shia E3 to
residues 95–117 of plectin isoform 1 (House et al. 2003).
Many other interaction partners have been identified,
among them the membrane skeleton proteins fodrin and
a-spectrin (Brown et al. 2001; Herrmann and Wiche,
1987), desmoplakin (Eger et al. 1997), bullous pemphigoid
antigen (BPAG) 1 and 2 (Koster et al. 2003; Steiner-
Champliaud et al. 2010), the outer nuclear membrane
protein nesprin 3 (Wilhelmsen et al. 2005), the tight
junction protein ZO-1 (zona occludens-1; Chen et al.
2006), and skeletal muscle-specific ankyrins (Maiweilidan
et al. 2011). The breast cancer susceptibility gene product,
BRCA2, which associates with the centrosome during S
and early M phase, interacts with plectin forming a com-
plex that controls centrosome localization (Niwa et al.
2009). Furthermore, plectin regulates FUS (fused in sar-
coma), an RNA-binding protein involved in transcription,
splicing, and mRNA transport, by sequestering it in the
cytoplasm (Thomsen et al. 2012).
Lately, it has become clear that plectin, in addition to
structurally reinforcing the cytoskeleton, acts as a scaffold
for molecules and proteins involved in signaling, by posi-
tioning them at specific sites within the cells. Examples are
the signaling molecule phosphatidylinositol-4,5-bisphos-
phate (PIP2; involved in the interaction of plectin with
actin; Andra¨ et al. 1998), the nonreceptor tyrosine kinase
Fer (requires plectin to turn down its autophosphorylation;
Lunter and Wiche 2002), the receptor for activated C
kinase 1 (RACK1; when bound to plectin downregulates
PKC signaling during the initial stages of cell adhesion;
Osmanagic-Myers and Wiche 2004), the c-subunit of
AMP-activated protein kinase (AMPK; associates with
Z-disk-bound plectin in differentiated myofibers; Gregor
et al. 2006), components of the MAP kinase Erk 1/2 sig-
naling pathway (required for controlled cell migration;
Osmanagic-Myers et al. 2006), the chemokine receptor
CXCR4 (plays an important role in stromal-derived factor-
1 signaling and trafficking, and in HIV-1 infection; Ding
et al. 2008), the RON receptor (a member of the Met proto-
oncogen family frequently overexpressed in pancreatic
cancer; Yu et al. 2012), and the NR3a subunit of the glu-
tamate receptor (Eriksson et al. 2007).
Plectin and human diseases
In 1996, several groups reported that mutations in the
plectin gene (PLEC) were the cause of autosomal recessive
forms of the skin disease epidermolysis bullosa simplex
associated with muscular dystrophy (EBS-MD; OMIM #
226670). Patients with EBS-MD lack plectin expression in
their cells due to premature stop codons coupled with
nonsense-mediated mRNA decay. In the meantime, other
forms of EBS have been ascribed to mutations in the
Fig. 2 Schematic
representation of proteins
known to interact directly with
plectin. Plectin is shown in the
center with the interacting
proteins grouped by their
cellular location or functional
categories. Abbreviations
(clockwise from top): HDs
hemidesmosomes, TJ tight
junctions, FAs focal adhesions,
NMJ neuromuscular junction,
MFs microfilaments, IFs
intermediate filaments, and MTs
microtubules. For details see
text
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plectin gene, such as EBS with pyloric atresia (EBS-PA;
OMIM #612138) and EBS-MD with myasthenic syndrome
(EBS-MD-MyS). The first and thus far only autosomal
dominant plectin mutation, known as EBS-Ogna (OMIM
#131950), was reported in 2002. Carriers of this mutation
suffer from a generalized skin fragility but do not show a
muscular phenotype. More recently, also patients, that
show only a muscular phenotype without skin abnormali-
ties, have been identified; these patients carry a mutation in
the first coding exon of isoform P1f (Gundesli et al. 2010).
More details about phenotypes caused by plectin mutations
will be given below.
A few recent reports have implicated plectin upregu-
lation in several types of epithelial cancers (Katada et al.
2012; Bausch et al. 2009; Lee et al. 2004; Pawar et al.
2011). Furthermore, plectin has been identified in a phage
display screen for biomarkers of pancreatic ductal ade-
nocarcinoma (Kelly et al. 2008). In this type of malignant
cells, plectin translocates to the cell membrane, whereas
in non-tumor cells, plectin is restricted to the cytoplasmic
compartment; concurrently, expression of plectin increa-
ses with tumor progression and metastasis (Bausch et al.
2009, Bausch et al. 2011). Due to the specificity of
plectin for premalignant and high grade pancreatic
lesions, plectin is being developed as an in vivo imaging
biomarker for pancreatic cancer (Bausch et al. 2011;
Konkalmatt et al. 2013).
Plectin in skin
Expression and subcellular localization
The analysis of plectin transcripts in murine skin revealed
expression of all eight plectin isoforms starting with alter-
native first coding exons (Fuchs et al. 1999). Immunofluo-
rescence microscopy of skin sections showed that P1a
expression was restricted to the basal (proliferating) kerat-
inocyte cell layer of interfollicular epidermis, whereas P1c
was found in basal as well as suprabasal (differentiating)
keratinocyte cell layers (Ackerl et al. 2007; Andra¨ et al.
2003; Walko et al. 2011) (Fig. 3a). Plectin, presumably P1a,
is also expressed in the outer root sheath of hair follicles
(Ackerl et al. 2007; Joubeh et al. 2003). Coexpression of
P1a and P1c in basal keratinocyte cell cultures has been
demonstrated on both, mRNA and protein levels (Andra¨
et al. 2003; Kostan et al. 2009; Walko et al. 2011), with P1a
being expressed at highest level (Andra¨ et al. 2003). Similar
to the in vivo situation, expression of P1c was maintained
when cultured keratinocyte monolayers were induced to
stratify and undergo terminal differentiation, whereas
expression of P1a was down-regulated (Kostan et al. 2009).
The most prominently expressed isoforms in epidermal
cells other than keratinocytes are P1 (Langerhans cells and
Thy 1.2-expressing T lymphocytes; Abrahamsberg et al.
2005) and P1c (melanocytes; unpublished observations of
the authors). In dermal fibroblasts, expression of plectin
isoforms P1, P1b, P1c, and P1f has been demonstrated
(Abrahamsberg et al. 2005; Burgstaller et al. 2010; Winter
et al. 2008), and, upon skin wounding, also the macrophages
and T lymphocytes infiltrating the dermis are P1 and P1f
positive (Abrahamsberg et al. 2005). In addition to full-
length plectin isoforms, variants lacking the central rod
domain have been detected in cultured keratinocytes and/or
dermal fibroblasts on mRNA as well as protein levels
(Koster et al. 2004; Natsuga et al. 2010a, b).
Specific functions of isoforms
P1a: key element for assembly and homeostasis of HDs
Based on plectin’s prominence at plasma membrane junc-
tional sites of keratin IFs in the epidermis (Wiche et al.
1983, 1984), it had been anticipated early on that plectin
could be a component of HDs and desmosomes. HDs are
specialized IF-associated multiprotein complexes that
provide stable adhesion of basal epithelial cells to the
underlying basement membrane in stratified as well as
certain complex and simple epithelia (Margadant et al.
2008), while desmosomal complexes link IFs to sites of
intercellular adhesion. In contrast to HDs, desmosome-like
structures are also found in non-epithelial tissues, such as
heart and skeletal muscle (Delmar and McKenna 2010,
Green and Simpson 2007). The high molecular mass IF-
associated proteins, HD1 and IFAP300, later identified as
orthologs of plectin, had in fact been characterized in early
studies as component of HDs and desmosomes in bovine
tongue tissue and in a rat epithelial cell line (Hieda et al.
1992; Skalli et al. 1994). The first evidence for isoform P1a
being a hemidesmosomal protein was provided by immu-
nogold electron microscopy of rat skin applying isoform-
specific antibodies (see Rezniczek et al. 1998, Fig. 9),
before a series of subsequent studies clearly established
P1a as the plectin isoform specifically associating with
HDs (Andra¨ et al. 2003; Kostan et al. 2009).
Studies in cultured keratinocytes have demonstrated that
the association of integrin a6b4 with P1a via the integrin b4
subunit and their clustering is crucial for the formation of
HDs. This initial P1a/integrin b4 association fosters the
recruitment of BPAG2 and BPAG1e molecules to the
complex and the anchorage of the keratin IF network
through P1a and BPAG1e follows (Hopkinson and Jones
2000; Koster et al. 2003; Litjens et al. 2006). Additional
stabilization of HDs against mechanical stress appears to be
mediated by lateral interaction of P1a molecules via their
rod domains (Walko et al. 2011). This notion is also
38 Histochem Cell Biol (2013) 140:33–53
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supported by the fact that rodless isoforms can only par-
tially substitute for full-length P1a in maintaining HD
function in skin of EBS-MD patients (Koster et al. 2004;
Natsuga et al. 2010a, b). Lateral aggregation of P1a mole-
cules in HDs also appears to protect P1a from degradation
via calpains, a family of calcium-dependent proteases that
could be involved in HD destruction to mediate migration
and terminal differentiation (Kostan et al. 2009; Walko
et al. 2011). The importance of the integrin subunit b4-P1a
interaction is confirmed in vivo by the much reduced level
or complete absence of HDs in mice deficient in either
plectin, or integrin subunits a6 and b4, which are born with
large patches of detached epidermis and generally die
within a few hours after birth (Andra¨ et al. 1997; Dowling
et al. 1996; Georges-Labouesse et al. 1996; van der Neut
et al. 1996). Similarly, the anchorage of keratin IFs at HDs
was found to be compromised in mice carrying null alleles
of either plectin or BPAG1e (Andra¨ et al. 1997; Guo et al.
1995), or in knock-in mice carrying the dominant negative
Ogna mutation (Walko et al. 2011). Furthermore,
underscoring the importance of P1a for HD function, skin
blistering due to compromised assembly and function of
HDs was observed in EBS-Ogna mice (having reduced P1a
levels), but not in mice that were deficient in P1c (Fuchs
et al. 2009; Walko et al. 2011).
Studies of adult mice carrying conditional deletions of
either plectin or the integrin subunit a6 in the epidermis
indicated that in vivo HDs are very stable structures,
exhibiting a very low turnover (Ackerl et al. 2007; Ni-
culescu et al. 2011). However, under certain circumstances,
such as wound healing or carcinoma invasion, HDs in
migrating and proliferating keratinocytes turn into highly
dynamic structures, similar to keratinocytes cultivated
ex vivo where HDs assemble and disassemble continuously
(Geuijen and Sonnenberg 2002; Ozawa et al. 2010). The
mechanism of HD disassembly has been addressed in
several studies. It was shown that P1a binds to integrin
subunit b4 via multiple interaction domains including its
N-terminal ABD (de Pereda et al. 2009; Koster et al. 2004;
Rezniczek et al. 1998). Growth factor-induced elevations of
Fig. 3 Expression of plectin isoforms in mouse skin and schematic
models of HDs. a Cryosections of adult mouse skin were subjected to
immunofluorescence microscopy using pan-plectin and isoform-
specific antibodies as indicated. Asterisks indicate basal cell mem-
brane separating epidermis (top) from dermis (bottom). Note, P1-
specific antibodies strongly stained dermal fibroblasts and epidermal
dendritic cells, but failed to stain the upper epidermal layers; staining
of basal epidermal keratinocytes was negligible. P1a immunoreac-
tivity was restricted to the basal membrane of basal keratinocytes,
while P1c-specific signals were more prominent in cells of the upper
epidermal layers. Anti-P1f antibodies showed specific but relatively
faint peripheral staining of upper layer keratinocytes. Bar 20 lm.
b Schematic drawing of the major components of skin HDs. The
transmembrane domain proteins integrin a4b6 and BPAG2 bind to
laminin 322 (Ln-322), a major component of the extracellular matrix,
and to the cytoplasmic proteins plectin and BPAG1, which in turn
connect to the keratin IF network. c Hypothetical model for HD
stabilization through plectin self-association. P1a clusters integrin
a6b4 molecules at the basal cell surface and strengthens the HD
through its association with keratin K5/14 filaments generating a
vertical force component (arrows pointing upwards). Lateral associ-
ation of dimeric P1a proteins via their rod domains generates an
additional (horizontal) force component that exerts cohesion and
compaction (opposing arrows). (b and c are modified from Rezniczek
et al. 2010 and Walko et al. 2011, respectively)
Histochem Cell Biol (2013) 140:33–53 39
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intracellular Ca2? levels lead to the activation of PKCa that
phosphorylates the integrin b4 subunit on serine and thre-
onine residues located in domains mediating the interaction
with plectin (Frijns et al. 2012; Margadant et al. 2008;
Rabinovitz et al. 2004), while Ca2?/calmodulin interacts
with P1a’s ABD (Kostan et al. 2009). Both events cause the
dissociation of P1a from membrane-bound integrin fol-
lowed by a redistribution of both proteins and disassembly
of HDs (see Kostan et al. 2009, Fig. 9).
P1c: regulator of MT dynamics in keratinocytes
The immunolocalization of P1c, the second major isoform
of plectin expressed in basal keratinocytes, reveals partial
colocalization with MTs, mostly in a dotted pattern
(Fig. 4a). Unexpectedly, and contrary to the function of
other cytolinker proteins previously analyzed, P1c has
recently been shown to act as a MT destabilizer (Valencia
et al. 2013). Compared to wild-type cells, MTs in P1c-
deficient keratinocytes were found to be more resistant
toward nocodazole-induced disassembly and to display
increased acetylation of tubulin, a modification indicating
reduced dynamic behavior. In addition, live imaging of
MTs in P1c-deficient as well as in plectin-null cells
revealed decreased MT dynamics. Accordingly, increased
MT stability in keratinocytes due to P1c deficiency led to
changes in a number of cellular properties and functions
known to be MT dependent, including altered cell shape,
increased velocity but loss of directionality of migration,
smaller-sized focal adhesions, higher glucose uptake due to
increased transfer of glucose transporters to the plasma
membrane, and mitotic spindle aberrations combined with
reduced growth rates of cells.
A mechanism proposed for microtubule destabilization
through P1c, based on ex vivo and in vitro assays, is
depicted by the cartoon shown in Fig. 4b. According to this
model, P1c is targeted to MTs via its isoform-specific
N-terminal sequence (including the ABD), while one of its
further downstream molecular domains, the SH3-like
domain embedded within its spectrin repeats (plakin
domain), interacts with MT-associated proteins (MAPs),
known stabilizers of MT polymers. Since the binding of
Fig. 4 P1c: a MT destabilizer. a Deconvolved immunofluorescence
microscopy images of cytoplasmic regions of wild-type (left and
middle panel) and P1c-deficient (right panel) keratinocytes. Anti-
bodies used are indicated; merged triple- or double-channel images
are shown. Note dotted decoration of MTs by both, P1c and MAP2, in
wild-type cells, whereas in P1c-deficient cells, MTs were decorated
with MAPs over much longer distances. b Proposed mechanism of
P1c-mediated MT destabilization. P1c, anchored to IFs via its
C-terminal IF-docking site (red sphere), binds to MTs via its isoform-
specific N-terminal sequence (including the ABD), while the SH3
domain located within the spectrin repeats (SH3/SR) binds to MAPs.
Interference with the MT-stabilizing function of MAPs ensures a
dynamic MT network in wild-type cells (left panel), whereas in P1c-
deficient cells, more MAPs can bind along MTs leading to their
stabilization (right panel). (a and b correspond to parts of Fig. 9 in
Valencia et al. 2013)
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plectin’s SH3 domain antagonizes the MT-stabilizing and
assembly promoting function of MAPs, P1c interaction
with MTs leads to MT destabilization, which in turn favors
a dynamic state of the MT network in cells. On the other
hand, when P1c is absent, such as in P1c-deficient cells,
more MAPs are bound along MTs (Fig. 4a) leading to the
stabilization of the polymer (Fig. 4b). Based on experi-
ments in which truncated forms of P1c were expressed into
P1c-deficient keratinocytes to assess their potential for
rescuing MT deficits, it was concluded that normal MT
properties could be restored in P1c-deficient keratinocytes
only if P1c variants were used that contained the C-ter-
minal IF-binding domain of the molecule and thus were
able to associate with the keratin IF network (Valencia
et al. 2013). Hence, beyond revealing an unexpected and
novel function of P1c and plectin in general, this study
opened an intriguing new perspective on how the cyto-
skeleton regulates its dynamics by uncovering the potential
of IFs to destabilize MTs via an associated cytolinker
protein, thereby stimulating MT dynamics.
P1: the missing link to the nucleus of skin cells and a role
in migration?
Plectin has been shown to bind to the outer nuclear enve-
lope protein nesprin 3a, thereby linking IFs to the nucleus
in keratinocytes, fibroblasts, and other cell types (Ketema
et al. 2007; Wilhelmsen et al. 2005). It remains to be
established which plectin isoform is associated with ne-
sprin 3a. P1 would definitively be a good candidate, as
studies in muscle tissue indicated that P1 is a major linker
component between IFs and the nuclear/ER membrane
(Konieczny et al. 2008; Rezniczek et al. 2007). Indeed, P1
transcripts have been identified in cultured keratinocytes
(Andra¨ et al. 2003).
The analysis of primary dermal fibroblasts derived from
isoform P1-deficient mice revealed abnormalities in the
actin cytoskeleton and an impaired migration potential of
the cells (Abrahamsberg et al. 2005), reminiscent of plec-
tin-null fibroblasts (Andra¨ et al. 1998). Along these lines, in
skin wound healing experiments carried out with P1-defi-
cient mice, reduced leukocyte infiltration was observed
during in vivo wound healing, and P1-deficient T cells
isolated from lymph nodes of these mice showed dimin-
ished chemotactic migration ex vivo (Abrahamsberg et al.
2005). While these findings demonstrate that P1 is involved
in the regulation of leukocyte recruitment during skin
wound healing, the underlying mechanism remains to be
determined. Nuclear positioning via P1-IF networking
could possibly play a role.
Special functions of other isoforms expressed in epi-
dermal and/or dermal skin cells, particularly of P1f, have
not been analyzed. Based on P1f’s predominantly
peripheral localization in keratinocytes (Fig. 3a), fibro-
blasts, and myofibers (see below), a role of this isoform in
actin-network regulation (Andra¨ et al. 1998), in addition to
its IF-anchoring function, is not unexpected.
Human skin disease phenotypes caused by plectin
mutations
In 1996, several groups reported that patients suffering
from the skin blistering disease epidermolysis bullosa
simplex with muscular dystrophy, lacked plectin expres-
sion in skin and muscle tissues due to defects in the plectin
gene (Chavanas et al. 1996; Gache et al. 1996; McLean
et al. 1996; Pulkkinen et al. 1996; Smith et al. 1996). Since
then, mutations within the plectin gene were identified in
an increasing number of EBS variants with skin involve-
ment. These variants include EBS-MD, EBS-MD-MyS,
EBS-PA, and EBS-Ogna (reviewed in Rezniczek et al.
2010; Winter and Wiche 2013). In all plectin-associated
EBS variants, skin blistering is caused by trauma-induced
rupture of basal epidermal keratinocytes in their cytoplasm,
usually at a level just above the basal cell membrane-
anchored HDs. Cell integrity in the suprabasal keratinocyte
cell layers is generally not affected, and cell–cell interac-
tions are preserved.
Until now, there are reports of 30 independent cases of
EBS-MD, in which the diagnosis was confirmed by iden-
tifying the mutation (see Table 1 in Winter and Wiche
2013; and additional cases reported in Charlesworth et al.
2013). At the molecular level, EBS-MD is frequently
associated with nonsense, insertion, or deletion mutations,
resulting in premature stop codons within exon 31, the
exon that encodes plectin’s coiled coil rod domain. This
predicts truncated polypeptides and mRNA downregulation
through nonsense-mediated mRNA decay. As processing
of the rodless variant of plectin remains unaltered by
mutations in exon 31 and as the expression of the rodless
isoform has been detected in cells of EBS-MD patients
(Koster et al. 2004; Natsuga et al. 2010a, b), it has been
postulated that rodless plectin could partially rescue some
basic functions of plectin in association with its N- and
C-terminal domains. EBS-MD was further found to be
caused by several in-frame insertion and deletion mutations
in exons located up- or downstream of exon 31 (Charles-
worth et al. 2013; Winter and Wiche 2013). It is likely that
these mutations affect specific protein–protein interactions
relevant for the proper functioning of plectin in HDs. In
general, clinical phenotypes of affected individuals vary
considerably with respect to severity of skin blistering. In
addition to congenital skin blistering, deformation of the
nails and tooth decay were observed in a number of EBS-
MD patients, and in some cases, erosive lesions on the oral
or laryngeal mucosa, hoarseness, respiratory complications
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during infancy, and urethral strictures have been reported
(Babic et al. 2010; Charlesworth et al. 2013; Kunz et al.
2000; Schara et al. 2004).
EBS with pyloric atresia (EBS-PA) is one of the most
severe EBS variants. It manifests as severe generalized
neonatal skin blistering and gastric abnormalities (pyloric
or duodenal atresia) and frequently leads to early postnatal
demise of affected individuals. Eleven patients with EBS-
PA have been reported so far carrying homozygous or
compound heterozygous mutations (Charlesworth et al.
2013; Winter and Wiche 2013). The majority (9) of EBS-
PA-associated mutations have been localized in exons
encoding the N-terminal region of plectin, some (6) were
found in exon 32 encoding the C-terminal domain, and
only one (situated at the very distal portion of exon 31)
affects the rod domain of plectin. This specific localization
pattern of mutations suggests that the EBS-PA phenotype
could result from genetic mutations specifically affecting
the N- and C-terminal portions of plectin that are harboring
the integrin b4- and IF-binding sites. Moreover, since these
mutations are mostly outside of the rod, premature termi-
nation will lead to loss of expression of both, full-length
and rodless, plectin isoforms (Charlesworth et al. 2003;
Natsuga et al. 2010a), and thus to a more severe phenotype.
Interestingly, a first case of non-lethal EBS-PA improving
with age has recently been reported (Charlesworth et al.
2013). This clinical phenotype was found to be caused by
two compound heterozygous mutations resulting in pre-
mature termination codons within exons 30 and 32. Con-
sidering that one of the mutations allows the synthesis of a
truncated version of the plectin molecule missing only its
most C-terminal part (PRD 6 and tail) and that low but
detectable expression of plectin has been demonstrated in
the patient’s epidermis, it has been proposed that the
truncated protein, which still harbors the critical residues
for integrin a6b4- and IF-binding, could partially com-
pensate for the loss of plectin expression from the other
allele (Charlesworth et al. 2013).
EBS-MD-MyS is a rare EBS variant that has been
diagnosed in three patients with compound heterozygous
PLEC mutations (Banwell et al. 1999; Forrest et al. 2010;
Selcen et al. 2011), and additionally in one patient with a
homozygous insertion mutation in the gene encoding the
acetylcholine receptor subunit CHRNE (Maselli et al.
2010). Three of the patients revealed marked skin blistering
from birth, whereas one exhibited only sparse signs of
epidermolysis bullosa (Banwell et al. 1999; Forrest et al.
2010; Selcen et al. 2011).
Besides the recessive forms of plectin-linked EBS, there
is one autosomal dominant form designated EBS-Ogna.
This rare mutation was originally identified in a kindred
near the small Norwegian town of Ogna (hence its name)
and later in four unrelated German families and two Dutch
individuals (Bolling 2010a; Gedde-Dahl 1971; Kiritsi et al.
2013; Koss-Harnes et al. 2002). EBS-Ogna is caused by a
heterozygous missense mutation, R2000 W, within plec-
tin’s rod-encoding exon 31 (Kiritsi et al. 2013; Koss-Har-
nes et al. 2002). In contrast to the other more severe
plectin-associated EBS variants, EBS-Ogna has a mild
course with localized acral skin blistering and formation of
erosions, which predominate with increasing age (Kiritsi
et al. 2013; Koss-Harnes et al. 2002). Other skin-related
symptoms encompass posttraumatic violaceous macules,
hypopigmented macules, mild focal palmoplantar kerato-
derma, and pitting of the teeth (Kiritsi et al. 2013; Koss-
Harnes et al. 2002). EBS-Ogna patients do not develop
MD, nor do they show signs of PA. The molecular mech-
anisms underlying the unique skin phenotype have been
shown to involve the isoform-specific proteolytic degra-
dation of P1a in HDs of basal keratinocytes (Walko et al.
2011). Besides being the only mutation with an autosomal
dominant type of inheritance reported thus far, the Ogna
mutation is emerging as the most frequent mutation of
plectin described in families of different ethnic origins,
suggesting that it may represent a hotspot for mutations
within the plectin gene.
Mouse models for plectin-related skin blistering
diseases
To mimic the clinical features of plectin-associated skin
blistering diseases in an animal model, several transgenic
mouse lines have been generated. The first was a plectin-
null mouse (Andra¨ et al. 1997), followed by a conditional
knockout mouse line, where the ablation of plectin was
restricted to keratin 5-expressing epithelia (K5-Cre/cKO;
Ackerl et al. 2007). Within 1 to 2 days after birth (occa-
sionally even at birth), plectin-null mice begin to show
signs of gross skin blistering, especially at fore- and
hindlimbs and, in some cases, around the mouth and nasal
cavities (Andra¨ et al. 1997). In K5-Cre/cKO mice, skin
blistering develops with a similar onset, body distribution,
and severity (Ackerl et al. 2007). In some cases, plectin-
null and K5-Cre/cKO mice are born with denuded paws
(authors’ unpublished observations), resembling aplasia
cutis congenita, similar to the most severe cases reported
for plectin-associated EBS-PA (Charlesworth et al. 2003,
2013; Nakamura et al. 2005; Pfendner and Uitto 2005). In
plectin-null mice, blisters on the lower extremities are
often hemorrhagic (Andra¨ et al. 1997), which, however, is
not observed in K5-Cre/cKO mice (authors’ unpublished
observations). This type of bleeding might indicate a pos-
sible perturbation of vascular endothelial cells, which
normally express plectin at relatively high levels (Errante
et al. 1994; Wiche et al. 1983). Epidermal desmosomes and
consequently cell–cell interactions were found to be
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unaffected by keratinocyte-specific deletion of plectin
(Ackerl et al. 2007). Inspection of the upper gastrointesti-
nal tract of newborn K5-Cre/cKO mice after at least one
nursing revealed the presence of multiple blisters on their
palates and in some cases also on their tongues but not in
the esophagus. Thus, plectin knockout mice seem to die
from malnutrition as a consequence of blistering of the oral
epithelia and possibly obstruction of the oral cavity by
especially large blisters or cellular debris (Ackerl et al.
2007). Recently, a mouse line carrying the EBS-Ogna
mutation has been generated (Walko et al. 2011). EBS-
Ogna mice mimic the human disease by displaying mild
skin fragility but no extracutaneous pathologies. The skin
phenotype of EBS-Ogna mice reflects sparse and dysfunc-
tional HDs, and insufficient protein levels of (HD-associ-
ated) P1a, whereas P1c is maintained at normal levels
(Walko et al. 2011). Noteworthy, HD deficiency in basal
keratinocytes of the epidermis could be partially restored by
treating mice with calpain inhibitors, setting the stage for
further exploration of treatment strategies for the disease.
Plectin in skeletal muscle
Expression and subcellular localization
The original immunolocalization of plectin in mammalian
tissues and isolated cardiomyocytes showed a prominent
association with desmin at Z-disks of skeletal muscle,
dense plaques of smooth muscle, and Z-disks and interca-
lated disks of cardiac muscle (Wiche et al. 1983; Zernig
and Wiche 1985). Using immunogold labeling, a number
of studies extended these findings to the ultrastructural
level. It was shown that plectin-positive filamentous
structures radiating from Z-disks were linked to desmin IFs
generating lateral linkages among adjacent Z-disks (Hi-
jikata et al. 1999, Reipert et al. 1999; Schro¨der et al. 1999)
and that similar bridges were connecting Z-disks of
peripheral myofibrils to sarcolemmal densities presumed to
represent costameric remnants (Hijikata et al. 2003; Rei-
pert et al. 1999; Rezniczek et al. 2007; Schro¨der et al.
1999). Furthermore, plectin was shown to be associated
with desmin IFs linking myofibrils to mitochondria at the
level of the Z-disk and along the entire length of the sar-
comere (Reipert et al. 1999). These studies strongly sug-
gested that the desmin IF network in partnership with
plectin was forming an extensively connected three-
dimensional intermyofibrillar and subplasma membrane
protein scaffold that physically linked the contractile
apparatus to internal organelles and to junctional com-
plexes at the sarcolemma, thus providing a mechanical
continuum between internal myofiber structures and the
extracellular matrix surrounding the fiber.
Specific functions of isoforms
In skeletal muscle tissue, all eight of the originally iden-
tified transcript variants containing alternatively spliced
first coding exons were found to be expressed, although for
some of the first exons, very weak signals were obtained by
RNase protection assays (Fuchs et al. 1999). Moreover, a
tissue-specific dominance of isoform P1d was detected,
which was most prominent in skeletal muscle and heart.
Beyond P1d, the muscle-specific set of major isoforms
comprises P1, P1b, and P1f, with relative transcript levels
of[10:4:3:1 for P1d, P1f, P1b, and P1, respectively (Fuchs
et al. 1999). Visualization of GFP fusion proteins upon
forced expression in cells (Rezniczek et al. 2003, 2007),
and immunofluorescence microscopy of teased muscle
fibers using isoform-specific antibodies (Konieczny et al.
2008), demonstrated that the various isoforms were tar-
geted to distinct subcellular locations, where, as it turned
out, they are fulfilling distinct functions (Fig. 5a; see also
Fig. 8 in Konieczny et al. 2008).
P1d: the Z-disk anchor protein of desmin filaments
P1d is the only isoform of plectin that is specifically
expressed in skeletal and cardiac muscle, but not in other
tissues (Fuchs et al. 1999). When GFP fusion proteins of
P1d were expressed in differentiated myoblasts, they were
found to be targeted exclusively to Z-disks (Rezniczek
et al. 2007). Furthermore, when cryosections of skeletal
muscle from isoform-specific P1d knockout mice were
immunolabeled using antibodies recognizing all isoforms
(anti-pan-plectin), only the sarcolemma and dotty remnants
in the interior of fibers were stained, contrasting the highly
ordered cross-striated staining pattern typical of wild-type
tissue. Similarly, in fibers of P1d-deficient muscle, plectin
signals were preserved in peripheral, perinuclear, and
costameric regions, where P1 and P1f were still present.
Moreover, in P1d-deficient muscle tissue and teased mus-
cle fibers, aggregates of desmin IFs were observed in the
interior but not peripheral areas of the fiber. While these
observations clearly show that P1d is responsible for the
recruitment and anchorage of desmin IFs to Z-disks, the
question how P1d itself is specifically targeted to Z-disk
structures is still unsolved. It will be a challenging task to
answer this question considering that the isoform-specific
sequence of P1d preceding its ABD (common to all iso-
forms) comprises only 5 amino acid residues.
P1f: plugging the contractile apparatus to the sarcolemma
In fibroblasts, P1f was shown to be an integral component of
mature, focal adhesion-evolved fibrillar adhesions, which
are characterized by their robust, fibronectin fibril-aligned,
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elongated structure, and central subcellular localization.
P1f-mediated vimentin IF network formation at these sites
creates a resilient cage-like core structure of IFs that
encases and positions the nucleus while being stably con-
nected to the exterior of the cell (Burgstaller et al. 2010).
The situation in muscle fibers seems to be similar. The
forced expression of GFP-labeled P1f in differentiated
myotubes showed that the fusion protein was targeting
exclusively to the sarcolemma where it associated with the
dystrophin-glycoprotein complex (DGC; Rezniczek et al.
2007). In fact, plectin binds directly to dystrophin and the
transmembrane laminin receptor b-dystroglycan, two of the
major DGC constituent proteins, via two independent
binding sites located in its N-terminal portion (see Fig. 5),
leaving its C-terminal IF-binding site freely accessible
(Rezniczek et al. 2007). In this way, P1f can act as a well-
anchored docking site for desmin IF networks that link
costameres (and associated structures in the extracellular
compartment) with peripheral myofibrils, mitochondria,
and myonuclei (see Fig. 5a). Based, among others, on the
strikingly similar expression patterns of P1f and dystrophin
during differentiation of myoblasts to myotubes, a role of
P1f in the formation and maturation of costameres has been
suggested (Rezniczek et al. 2007), reminiscent of the
transformation of focal adhesions to fibrillary adhesion in
fibroblasts. In certain types of mature muscle fibers, such as
fast type 2A fibers of quadriceps muscle from adult mice,
P1f could additionally be found at Z-disks, suggesting a
Fig. 5 Plectin in skeletal
muscle. a Schematic
representation of plectin’s
isoform diversity and specific
functions. The four major
isoforms expressed in muscle,
P1d (yellow), P1f (dark blue),
P1b (green), and P1 (purple) are
site-specifically bound via their
N-terminal molecular domains





and the nuclear/ER membrane
system (P1). The various
isoforms recruit (via their
C-terminal IF-binding domain)
the desmin IF network (blue
lines) to their specific locations,





organelles, the sarcolemma, and
the extracellular compartment.
b Immunofluorescence
microscopy of teased muscle
fibers from wild-type and
conditional muscle-restricted
knockout (MCK-Cre/cKO)
mice. Visualized proteins are
indicated; myonuclei are stained
in blue. Note massive formation
of desmin-positive protein
aggregates and misaligned and
disoriented Z-disks, both
hallmarks of myofibrillar
myopathies, in specimens of
mutant mice (corresponds to
Fig. 2D in Konieczny et al.
2008)
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certain degree of interchangeability of plectin isoforms
once IF-docking sites have been formed and become
functional (Rezniczek et al. 2007).
What seems to be most crucial for myofiber integrity is
the structural axis generated by P1d and P1f that interlinks
sarcomeres at their Z-disks and connects them with the
plasma membrane. Disruption of one (P1d) or both (P1f
and P1d) of these IF-linking elements inevitably leads to
the loss of muscle fiber integrity. In fact, as demonstrated
by isoform-specific gene targeting, elimination of P1d
alone leads to the formation of aggregates in the interior of
the fiber, but not in its peripheral sarcolemmal regions.
Despite that in this case, the remaining P1f was able to
preserve costameric IF structures; isoform P1d knockout
mice showed a similarly severe muscle phenotype as the
conditional knockout mice (lacking all isoforms), or des-
min-null mice (Konieczny et al. 2008).
P1b: integrating mitochondria into the desmin IF network
Colocalizing with mitochondria, P1b acts as a direct linker
between the organelle and the desmin network. This link-
age has been demonstrated for IFs of the vimentin and
desmin type, but most likely occurs also with other types of
IFs. The exon 1b-encoded sequence of this isoform serves
as a mitochondrial targeting and anchoring signal, inserting
the protein into the outer mitochondrial membrane via its
N-terminal part. The bulk of the protein remains in the
cytosol, where it interacts via its C-terminal high-affinity
binding site with IFs recruiting them to the organelle
(Winter et al. 2008). In fact, the loss of P1b leads to marked
shape changes of mitochondrial networks, manifesting as
elongation of mitochondrial networks in P1b-deficient
fibroblasts and myoblasts (Winter et al. 2008). Moreover,
in muscle tissue that is deficient in P1d (but not P1b),
association of residual plectin with mitochondria and
colocalization of collapsed desmin IFs with mitochondrial
aggregates were observed; whereas in plectin-null muscle,
similar to P1b-deficient muscle, this was not the case
(Konieczny et al. 2008). The underlying mechanism of
mitochondrial network deregulation through P1b defi-
ciency and its biological significance remain to be deter-
mined. However, there is evidence that mitochondrion-
bound plectin, in addition to having a positioning effect,
serves as a scaffolding platform for signaling complexes
(Winter et al. 2008).
P1: linking desmin IFs to the nuclear/ER membrane system
In muscle fibers, contrary to other isoforms, P1 localizes
primarily to the outer nuclear/ER membrane system (Re-
zniczek et al. 2007, Konieczny et al. 2008). Exon 1 encodes
a putative nuclear localization signal (NLS), and
N-terminal fragments of P1 up to a certain length exhibit
nuclear localization (Rezniczek et al. 2003). Thus, the NLS
domain is likely to play a role in recruiting P1 to the
nuclear/ER membrane, where upon binding to other local
interaction partners, it forms a recruitment platform for IFs.
One of these putative proteins has been identified as ne-
sprin-3, a KASH domain-containing protein that interacts
with plectin’s ABD (Ketema et al. 2007). As nesprin-3 is
an outer nuclear membrane protein, it provides via plectin a
direct link between the nuclear envelope and the cyto-
plasmic IF network (Ketema and Sonnenberg 2011). Other
nuclear/ER membrane-associated proteins that bind
directly either to the isoform-specific sequence or to other
molecular domains of P1 are expected to be found. In
addition to the nuclear/ER membrane system, P1 showed
partial association with the sarcolemma in certain types of
fully differentiated muscle fibers (Rezniczek et al. 2007).
Thus, like P1f, P1 may show spatial interchangeability with
other isoforms at mature or late stages of myofiber
development.
The isoform-specific N-terminal sequence of P1 (180
amino acid residues) is the longest of all known plectin
isoforms. One of its specific features is that it contains a
binding site of unusual high activity for the substrate-
binding site of Siah, a ring domain protein functioning in
E3 ubiquitin ligase complexes that mediate degradation of
a wide range of cellular proteins. It has therefore been
suggested that P1 could serve as a dominant negative
regulator of Siah proteins (House et al. 2003).
Skeletal muscle phenotypes of plectinopathy patients
Plectin has been found to be prominently expressed in
muscle cells early on, but its importance for the structure
and function of muscle became clearly evident only when
patients with defects in the plectin gene were found to
suffer, in addition to skin blistering, from late onset mus-
cular dystrophy (for a recent review see Winter and Wiche
2013). The clinical phenotypes of patients vary consider-
ably with respect to onset and progression of muscular
symptoms as well as severity of skin blistering. Skeletal
muscle weakness usually starts in the second decade of life
and shows relatively slow disease progression leading to a
loss of ambulation after 10–20 years by affecting facial,
extraocular, limb, and trunk muscles. Moreover, patients
with cardiac pathology have been reported that display
asymptomatic left ventricular hypertrophy (Schro¨der et al.
2002) and adult-onset biventricular dilated cardiomyopathy
(Bolling et al. 2010b). Similar to skin, immunofluorescence
microscopy of skeletal muscle tissue of EBS-MD patients
revealed either drastically reduced or completely absent
plectin-specific staining (McMillan et al. 2007). While
antibodies recognizing epitopes in the central rod domain
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of plectin in general lack immunoreactivity, antibodies
directed against plectin’s C- or N-terminal regions often
revealed specific signals, indicating the expression of
rodless or truncated plectin versions, which might attenuate
the clinical phenotypes (Koster et al. 2004; Natsuga et al.
2010a, b). Immunolabeling for desmin usually reveals the
formation of cytoplasmic and subsarcolemmal desmin-
positive protein aggregates. Moreover, ultrastructural
analyses of skeletal muscles showed disarrayed myofibrils
and loss of sarcomeric organization, accompanied by
pathological changes of membranous organelles and neu-
romuscular endplates (Bauer et al. 2001; McMillan et al.
2007; Schro¨der et al. 2002). Therefore, most plectinopa-
thies can be assigned to the group of myofibrillar myopa-
thies (MFMs), an expanding group of clinically and
genetically heterogeneous muscle diseases characterized
by misfolded proteins and pathological desmin-positive
protein aggregates, myofibrillar degeneration, and mito-
chondrial abnormalities (Ferrer and Olive 2008; Schro¨der
and Schoser 2009). EBA-PA cases do not display signs of
muscular pathology; however, onset of MD is to be
expected if patients survive long enough (Charlesworth
et al. 2013, Winter and Wiche 2013).
Muscular symptoms are displayed also by patients suf-
fering from EBS-MD-MyS or LGMD2Q. EBS-MD-MyS
patients show first signs of muscle weakness accompanied
by myasthenic symptoms within the first decade of life. In
fact, defects in neuromuscular transmission, as demon-
strated by a pathological decremental response in neuro-
muscular transmission studies, were observed in all cases.
Recently, a homozygous 9-bp deletion in the isoform-
specific sequence of P1f was found to cause limb-girdle
muscular dystrophy type Q2 (LGMD2Q), characterized by
a muscular pathology without any skin involvement
(Gundesli et al. 2010). In this case, the probands suffered
from early-onset limb-girdle syndrome with loss of
ambulation in their late twenties. As distinct isoforms
perform different functions, mutations in other isoforms
can be expected to be identified in the future and should be
considered in cases of undiagnosed muscular dystrophies.
Mouse models for plectin-related muscular dystrophies
Plectin-null mice, similar to plectinopathy patients, show
abnormalities reminiscent of minicore myopathies mani-
festing in skeletal muscle as focal loss of myofibrils and
disruption of sarcomeres affecting Z-lines and adjacent
myofibrils, Z-band streaming, and increased amounts of
necrotic fibers (Andra¨ et al. 1997), and in heart as disin-
tegration of intercalated disks. However, as these mice die
within 2–3 days after birth, they are of limited use as
animal models for plectin-related muscular dystrophies. To
overcome this problem, a conditional, striated muscle-
restricted plectin knockout mouse line (MCK-Cre/cKO)
was generated. Closely mimicking the human disease,
these mice show progressive degenerative alterations,
including aggregation and partial loss of desmin IFs,
aggregation and dysfunction of mitochondria, and a partial
detachment of the contractile apparatus from the sarco-
lemma (Konieczny et al. 2008). The analysis of these mice
showed that the disruption of myofibrils, and particular of
Z-disks, most likely occurs as a consequence of disruptive
contractions of myofibrils. Due to the loss of its anchorage
via plectin and the resulting defective lateral alignment of
myofibrils, the desmin IF network can no longer keep
sarcomeres in register. The additional formation of dys-
functional protein (desmin) aggregates in subplasma
membrane and interior cellular compartments contributes
to the deleterious phenotypes of plectin-deficient myofi-
bers. Mutant mice, mimicking the complex disease pattern
of human plectinopathies, and ex vivo myocyte cell cul-
tures derived from them, thus provide powerful tools for
elucidating functional and molecular consequences of
plectin gene defects leading to skeletal muscle pathology.
For three of the four major plectin isoforms expressed in
muscle, P1d, P1b, and P1, isoform-specific knockout
mouse lines were generated, which lack just one of these
isoforms, while expressing all others. Some of their phe-
notypes have been described above. In addition, a double
knockout mouse line, deficient in P1d and desmin has been
generated (Konieczny et al. 2008), and a muscle-restricted
conditional plectin knockout line lacking dystrophin in
addition to plectin has recently become available (Raith
et al. 2013). The phenotypic analysis of the latter unveiled
a new facet of plectin’s ever increasing functional reper-
toire by establishing a mechanistic link between sarco-
lemma-associated plectin, its microtubule-destabilizing
action, and glucose transporter–mediated glucose uptake of
muscle fibers (Raith et al. 2013).
Plectin in Schwann cells of peripheral nerve
Similar to skin and muscle tissues, plectin shows wide-
spread occurrence in neural cells and tissues (Errante et al.
1994), and neurodegeneration has been reported in some
cases of EBS-MD (Smith et al. 1996, Bauer et al. 2001).
Plectin has also been implied in Alexander disease, a
neurological disorder caused by mutations in GFAP (Tian
et al. 2006). The phenotypic analysis of isoform P1c-spe-
cific knockout mice revealed slightly reduced neurofila-
ment densities in some of their axons and significantly
reduced nerve conduction velocity in sciatic nerve (Fuchs
et al. 2009). Whether these alterations are mechanistically
linked remains to be shown. With respect to the diversity
and specific functions of isoforms, the best studied neural
46 Histochem Cell Biol (2013) 140:33–53
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cell system are myelinating Schwann cells of the peripheral
nerve.
Expression and isoform diversity
Immunolabeling of murine sciatic nerve using isoform-
specific antibodies revealed expression of P1 and P1c in the
cytoplasm and at the periphery of axons as well as in the
cytoplasm of myelinating Schwann cells (Fig. 6a; see also
Fuchs et al. 2009; Walko et al. 2013). In addition, relatively
strong P1-specific labeling of some neurofilament-negative
cells, probably representing endoneural fibroblasts was
noticed. P1a, the predominantly in stratified epithelial tis-
sues–expressed isoform, could not be detected in axons or
myelinating Schwann cells, but was found to be expressed
in putative endoneural fibroblasts; in these cells, also P1f,
one of the major isoforms of dermal fibroblasts (Burgstaller
et al. 2010) was detected. Faint, dotted signals of P1f were
also observed in axons, whereas myelinating Schwann cells
were found to be P1f negative. When the expression of
isoforms in cultures of primary Schwann cells and nerve
fibroblasts was assessed by immunoblotting of cell lysates,
the expression of full-length versions of isoforms P1, P1c,
and P1f was demonstrated for both types of cells. In
addition, in Schwann cell lysates, the corresponding rodless
isoform variants lacking the central rod domain were
detected at relatively high levels, whereas in nerve fibro-
blast samples, a rodless version was found only in the case
of P1 (Walko et al., 2013). Consistent with its in situ
visualization in tissues (Fig. 6a), P1a was detectable in
lysates of nerve fibroblast, but not Schwann cell cultures
(Walko et al. 2013).
Subcellular distribution
Confocal immunofluorescence microscopy of teased sci-
atic nerve fibers using antibodies that do not discriminate
between isoforms revealed codistribution of plectin and
vimentin IFs in longitudinal Cajal bands and transversing
trabeculae (Fig. 6b; Walko et al. 2013) which constitute
the cytoplasm of myelinating Schwann cells (Court et al.
2004). In cultured Schwann cells, plectin was found to
colocalize with the vimentin IF network as well as with
vimentin-positive short filamentous structures (Fig. 6c)
that most likely were representing filament precursors, as
previously reported for fibroblast cells (Spurny et al.
2008). Coimmunoprecipitation and immunolocalization
experiments revealed that plectin present in Cajal bands
formed a tight complex not only with vimentin but also
with b-dystroglycan, the core component of the DGC
(Walko et al. 2013). Thus, by anchoring vimentin IFs to
dystroglycan, plectin fulfills in myelinating Schwann
cells a similar function as in skeletal muscle where it
anchors the desmin network to the DGC (Rezniczek
et al. 2007).
Specific functions of isoforms
As recently shown, the binding of plectin to b-dystroglycan
and the ensuing recruitment of the vimentin IF network to
the abaxonal Schwann cell membrane contribute to the
stabilization of the dystroglycan complex (Walko et al.
2013). The Schwann cell-specific ablation of plectin in a
protein zero (P0)-Cre/conditional plectin knockout mouse
line (P0-Cre/cKO) was found to lead to faulty vimentin IF-
dystroglycan complex formation, leading to an aggravation
of aging-related destabilization of the myelin sheath
(Walko et al. 2013). In contrast to skeletal muscle, where
the loss of plectin causes massive aggregation of desmin
IFs (Konieczny et al. 2008), in myelinating Schwann cells,
the impact of plectin deficiency on the organization of the
vimentin IF system was detectable just as a decrease in the
vimentin IF network density in a fraction of nerve fibers
characterized by large caliber axons (Walko et al. 2013).
One possible explanation for this difference could be that
peripheral nerves in general are more protected and thus
less exposed to mechanical stress compared to skeletal
muscle fibers. The isoform of plectin acting as the specific
interaction partner of b-dystroglycan in differentiating
Schwann cells has still to be identified. Given the absence
of P1f in this type of cells (see Fig. 6a), the strongest
candidate for this function is P1, which has previously been
shown to interact with the DGC component a-dystrobre-
vin-1 (Hijikata et al. 2008). In this context, it is noteworthy
that albeit the P1a-specific binding partner integrin b4 is
expressed in myelinating Schwann cells (Nodari et al.
2008), cell-extracellular matrix junctions similar to HDs
are not formed by this type of cell, at least not at its fully
differentiated state, due to the lack of isoform P1a
expression.
Concerning potential roles of other Schwann cell-
expressed plectin isoforms, it is of interest that P1f is
abundantly expressed in ex vivo cultures of Schwann cells,
in contrast to fully differentiated (myelinating) tissue cells.
Given the established role of this isoform in regulating
focal adhesion turnover and cell shape in fibroblasts
(Burgstaller et al. 2010), its expression in ex vivo cell
cultures would be consistent with a role in cell migration, a
feature presumably required by precursor and regenerating,
but not fully differentiated Schwann cells. The role of P1c,
the other major plectin isoform identified in Schwann cells,
presently is unknown. Whether it performs MT-related
functions in Schwann cells, as it does in keratinocytes,
remains to be tested. Even if no alterations in the organi-
zation of MTs were observed in Cajal bands of sciatic
nerves from myelinating Schwann cell-specific knockout
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mice (Walko et al. 2013), P1c could still play a role in the
regulation of MT-dependent transport processes in the
cytoplasm of these cells. Of note, in contrast to isoform P1c
knockout mice, a defect in motor nerve conduction velocity
of sciatic nerve could not be detected in conditional,
Schwann cell-specific plectin knockout (P0-Cre/cKO) mice
(authors’unpublished data), suggesting that this phenotype
is specifically related to axonal P1c.
Perspective
Plectin has emerged as a preeminent cytoskeletal linker
protein controlling IF functions. Studies on skin, skeletal
muscle fiber, and Schwann cells, the systems discussed in
this review article, clearly showed that distinct cell types
express specific sets of plectin isoforms that are targeted to
distinct cellular locations. By recruiting IF networks to
their target sites, plectin isoforms control interior cytoar-
chitecture as well as cell shape, with in part dramatic
effects on mechanical resilience as well as an array of other
basic cellular function, among them proliferation, metab-
olism, migration, and signal transduction. In light of
plectin’s isoform diversity and IF partnership in practically
all mammalian cell types, the challenge for future relevant
research lays in the analysis of isoform-specific functions
and their mechanisms in systems other than the highly
stress-prone tissues discussed above. It will be of particular
interest to unravel the roles of plectin isoforms in the
development and function of the brain and of motor neu-
rons in the peripheral nervous system, as for both cases,
there is evidence for important physiological roles of
plectin, based on phenotypic analyses of plectinopathy
patients as well as plectin knockout mice; and a similar
situation pertains to the vascular system.
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